PRESS-RELEASE ·Filed Mar 12, 2026
Press release · Earnings
Actionable Insight • Neutral
Traders should monitor the upcoming earnings release on March 26 for revenue, EPS, and guidance trends, particularly given the company's small market cap of $23M and limited recent insider activity.
Final — all horizons settled through T+60d
IRIX ▼ -14.62% at T+60d
NEUTRAL call -14.62% · α vs SPY -26.23% · entry $1.30 → $1.11
T+1d
+2.31%
call +2.31% · α +1.28%
$1.33
settled 8mo ago
T+5d
+3.85%
call +3.85% · α +5.96%
$1.35
settled 7mo ago
T+20d
-20.77%
call -20.77% · α -24.36%
$1.03
settled 7mo ago
T+60d
-14.62%
call -14.62% · α -26.23%
$1.11
settled 5mo ago
Price Chart
Loading chart...
Executive Summary
IRIDEX Corporation announced plans to release its fourth quarter and full-year 2025 financial results on March 26, 2026, followed by a conference call. The press release contains no actual financial data, guidance, or material updates beyond the scheduling of the earnings announcement.
Key Facts
- IRIDEX will release Q4 and full-year 2025 financial results on March 26, 2026, after market close.
- Management will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET on the same day.
- No financial results, guidance, or business updates were disclosed in this announcement.
- The company operates in the ophthalmology space with MicroPulse® laser technology for glaucoma and retinal diseases.
Financial Impact
No financial data disclosed
Risk Factors
- Lack of disclosed financials limits ability to assess performance or trajectory ahead of the release.
- Small market cap increases volatility risk around earnings announcement.
Market Snapshot
Exchange
Nasdaq
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3255088 |
8 reports for IRIX
100% Hit rate @ T+20 Went positive at some point 3 of 3 best @ T+20▲ +16.76%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 18, 2026 10w ago | 8-K | $0.7829 $0.6517 | ▲ +16.76% | ▲ +14.81% | $0.7400 (+5.48%) |
Aug 18, 2026 10w ago | Press Release | $0.7829 $0.6517 | ▲ +16.76% | ▲ +14.81% | $0.7400 (+5.48%) |
Jul 16, 2026 14w ago | 8-K | $0.9510 $0.8241 | ▲ +13.34% | ▲ +16.96% | $0.7400 (+22.19%) |
May 19, 2026 23w ago | 8-K | $1.00 $1.13 | ▲ +13.00% | ▲ +12.26% | $0.7400 (−26.00%) |
Apr 24, 2026 26w ago | DEFA14A | $1.08 $1.04 | ▼ −3.70% | ▼ −8.66% | $0.7400 (−31.48%) |
Apr 7, 2026 29w ago | Press Release | $1.03 $1.05 | ▲ +1.94% | ▼ −6.60% | $0.7400 (−28.16%) |
Mar 26, 2026 30w ago | Press Release | $0.9900 $1.08 | ▲ +9.09% | ▼ −3.65% | $0.7400 (−25.25%) |
Mar 12, 2026 32w ago | Press Release | $1.30 $1.03 | ▼ −20.77% | ▼ −24.36% | $0.7400 (−43.08%) |
Showing 8 of 8
US Market Status
Market Closed — Opens Thu (11h 7m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers